Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse
Abstract
Virulence in the ubiquitous intracellular protozoon Toxoplasma gondii for its natural intermediate host, the mouse, appears paradoxical from an evolutionary standpoint because death of the mouse before encystment interrupts the parasite life cycle. Virulent T. gondii strains secrete kinases and pseudokinases that inactivate the immunity-related GTPases (IRG proteins) responsible for mouse resistance to avirulent strains. Such considerations stimulated a search for IRG alleles unknown in laboratory mice that might confer resistance to virulent strains of T. gondii. We report that the mouse IRG system shows extraordinary polymorphic complexity in the wild. We describe an IRG haplotype from a wild-derived mouse strain that confers resistance against virulent parasites by interference with the virulent kinase complex. In such hosts virulent strains can encyst, hinting at an explanation for the evolution of virulence polymorphism in T. gondii.
https://doi.org/10.7554/eLife.01298.001eLife digest
The parasite Toxoplasma gondii is one of the most common parasites worldwide and is known for its unusual life cycle. It reproduces sexually inside its primary host—the cat—and produces eggs that are released in faeces. Other animals, most often rodents, can then become infected when they unknowingly eat the eggs while foraging. Once inside its new host, the parasite reproduces asexually until the rodent’s immune system begins to fight back. It then becomes semi-dormant and forms cysts within the brain and muscle cells of its host. In an added twist, the parasite also causes rodents to lose their fear of cats. This increases their chances of being caught and eaten, thereby helping the parasite to return to its primary host and complete its life cycle.
Previous work has shown that virulent strains of T. gondii can evade the host immune system in mice by secreting enzymes that inactivate immune-related proteins called IRG proteins. This prevents the infection being cleared and leads to death of the host within a few days. The existence of these virulent strains is intriguing because parasites that kill their host, and thus prevent their own reproduction, should be eliminated from the population. The fact that they are fairly common suggests that there must be a hitherto unknown mechanism that allows rodents to survive these virulent strains.
Lilue et al. now report the existence of such a mechanism in strains of mice found in the wild. In contrast to laboratory mice, wild mice produce IRG proteins that inhibit the enzymes secreted by the virulent strains of T. gondii. Moreover, the IRG genes in wild mice are highly variable, whereas laboratory mice all have virtually identical IRG genes.
By uncovering the complexity and variability of IRG genes in wild mice—complexity that has been lost from laboratory strains—Lilue et al. solve the conundrum of how highly virulent T. gondii strains can persist in the mouse population, and offer an explanation for the evolution of parasitic strains with differing levels of virulence.
https://doi.org/10.7554/eLife.01298.002Introduction
A virulent parasite that overcomes the immune system and kills its host may seem to have won the confrontation, but it is a Pyrrhic victory when the early death of the host reduces the probability of parasite transmission. Indeed it is in the interests of all hosts and most parasites to prolong the encounter. In this sense, virulence is a failure of co-adaptation. Haldane’s conjecture (Haldane, 1949) that intense and fluctuating selection imposed by parasites will generate host protein polymorphism is widely accepted (Woolhouse et al., 2002; Clark et al., 2007; Kosiol et al., 2008; Fumagalli et al., 2011). The presence in a population of multiple host resistance alleles confronting multiple parasite virulence alleles may reflect a dynamic equilibrium permissive for the persistence of both parties. However this equilibrium is achieved only at the expense of individual interactions fatal for either the parasite or the host, as a consequence of confrontations of inappropriate alleles. In mammals, however, the ability of the adaptive immune system to respond within the time scale of an individual infection and to remember for a lifetime, buffers individuals against dangerous genetic novelty arising from parasites. As a result, life or death outcomes for common infectious diseases in mammals are not generally determined by single, highly penetrant, polymorphic genes. We here report such a case, involving infection of the house mouse, Mus musculus, with the ubiquitous intracellular protozoan parasite, Toxoplasma gondii. T. gondii has a complex life cycle (Dubey, 1998) (Figure 1). The sexual process occurs in true cats (Felidae) and intermediate hosts become infected by ingesting oocysts spread in cat faeces. A phase of fast intracellular replication and spread (tachyzoite phase) stimulates immunity in the intermediate host, and this in turn induces parasite encystment in brain and muscle cells and lifelong persistence. Predation of the infected host by a cat completes the life cycle. If immunity fails, tachyzoite replication continues uninterrupted, killing the infected host within a few days (Deckert-Schlüter et al., 1996). Thus the probability that T. gondii completes its life cycle, which is roughly linear with duration of infection of the intermediate host, depends on early immune control.
Mus musculus is probably the evolutionarily most important intermediate host for T. gondii, because it is very abundant worldwide and sympatric with a uniquely abundant felid, the domestic cat. Early immune control of T. gondii in mice depends on a family of IFNγ-inducible cytoplasmic effector proteins, the 47 kDa immunity-related GTPases (IRG proteins; for nomenclature of IRG genes and proteins see Bekpen et al. (2005); Martens and Howard (2006) and ‘Materials and methods’) (Taylor et al., 2000; Collazo et al., 2001; Liesenfeld et al., 2011). These assemble on the cytosolic face of the parasitophorous vacuole membrane (PVM), causing its rupture and killing the included parasite (Martens et al., 2005; Zhao et al., 2009b). In the C57BL/6 (BL/6) laboratory mouse strain about 20 IRG genes occur in two adjacent clusters on chromosome 11 and one cluster on chromosome 18 (Bekpen et al., 2005) (Figure 2A). The whole 47 kDa sequences of IRG proteins are typically translated from a single exon. Exceptional are certain ‘tandem’ IRGB proteins with a molecular weight of about 94 kDa. These genes are transcribed across two chromosomally adjacent IRG coding units and the intergenic spacer is spliced out as an intron resulting in a single open reading frame (Bekpen et al., 2005. See also ‘Materials and methods’ for a note on nomenclature of the tandem genes and proteins). IRG proteins fall into two major functional and sequence sub-families, the GKS group (IRGA, IRGB and IRGD proteins) that are effector proteins at the PVM, and the GMS group (Irgm1, Irgm2 and Irgm3) that are negative regulators of the GKS proteins (Hunn et al., 2008). Many strains of T. gondii (e.g., the abundant Eurasian strains designated types II and III) are well controlled by the IRG system in laboratory mice, encyst, and are considered avirulent. But others (e.g., type I) are highly virulent (Sibley and Boothroyd, 1992), killing the mouse host during the tachyzoite phase of infection. It has very recently been shown that virulence differences between T. gondii strains are largely due to polymorphic variation in ROP18 and ROP5 (Saeij et al., 2006; Taylor et al., 2006; Khan et al., 2009; Behnke et al., 2011), members of a family of kinases and pseudokinases (El Hajj et al., 2006). These proteins are secreted during parasite entry and accumulate on the cytosolic face of the PVM (Boothroyd and Dubremetz, 2008). Virulent ROP allotypes inactivate IRG effector proteins by phosphorylating essential threonines in the nucleotide-binding domain (Fentress et al., 2010; Steinfeldt et al., 2010). In view of the unique importance of Mus musculus for the transmission of T. gondii, parasite strains acutely lethal for mice should be counterselected. Their presence at a significant frequency therefore demands an explanation. In this paper, we reveal that the IRG resistance system in mice has a scale of polymorphic complexity that rivals the MHC, and that a resistant IRG haplotype in the mouse can counter polymorphic virulence factors in the parasite, generating a host phenotype that is permissive for encystment, and thus for the propagation, of virulent strains.
Results
We compared the IRG genes from a number of mouse strains, mostly those re-sequenced in the Mouse Genomes Project (Keane et al., 2011) with the canonical BL/6 sequences (Figure 2B). The re-sequenced mice are largely from established laboratory strains. Others are recently derived from the wild and not admixed with laboratory mice. Mus spretus is a wild species distinct from Mus musculus with a divergent history of 1–3 million years (Suzuki et al., 2004). Within laboratory strains we found relatively little IRG protein polymorphism on Chr 11. In contrast, the wild-derived strains showed variation in IRG gene number and remarkable protein polymorphism. For example Irgb6, a protein of 406 residues, had an allele in the CAST/EiJ strain with 47 amino acid substitutions relative to BL/6. On Chr 18, IRG protein sequence variation between laboratory strains was more apparent, and again, wild-derived strains showed extensive sequence polymorphism and copy number variation. The IRG proteins of the outgroup, M. spretus, showed considerable protein divergence from M. musculus sequences. Pseudogenes occurred in every haplotype and some (e.g. Irga5 and Irgb7) were preserved between M. musculus and M. spretus. Other IRG sequences were pseudogenes in some haplotypes and apparently intact in others, for example Irga3 and Irga8. Even within this limited group of strains we can distinguish eleven distinct IRG gene haplotypes on Chr 11 and thirteen on Chr 18, already yielding a theoretical population diversity of several hundred IRG genotypes. Diagonal dot-plot comparisons between IRG gene clusters of wild-derived CAST/Ei and MSM/Ms with BL/6 showed IRG genes within tracts of duplication and deletion, associated with numerous repeats in both orientations, a genomic configuration that would be expected to be dynamic even on short time-scales, and doubtless responsible for the two very different dot-plots (Figure 2C and Figure 2—figure supplement 2).
We added sequences amplified from genomic DNA of wild mice from several Eurasian sites (Figure 3—figure supplement 1) to the data from inbred strains to generate nearest neighbour phylograms (Figure 3A). We analysed five IRG genes, namely Irgm1, a regulatory IRG protein of the GMS class (Hunn et al., 2008), and Irga6, Irgb2, Irgb6, and Irgb10, all effector GKS proteins localizing to the T. gondii PVM during infection (Khaminets et al., 2010). Irgb2 forms the N-terminal half of the tandem protein, Irgb2-b1. The nearest-neighbour phylograms of Irgm1, Irgb10 and Irga6 are shallow and the M. spretus sequences fall into outgroups. Thus most of the sparse polymorphic variation in these sequences has been acquired since the divergence of M. musculus from M. spretus. This conclusion is supported by a tendency for individual minor variants to be concentrated in one or other of the three recent, geographically separated and partially isolated subspecies, Mus musculus musculus, Mus musculus domesticus and Mus musculus castaneus (Figure 3A, Figure 3—figure supplements 2–4). In contrast, the phylograms for Irgb2 and Irgb6 have a depth similar to the mouse-rat divergence (about 20 million years) (Gibbs et al., 2004), the M. spretus sequences are embedded in the M. musculus trees, and any tendency to correlation with subspecies is seen only in the outermost branches. Thus the polymorphism in these two genes is ancient and has persisted through a number of speciation events. The scale of polymorphism in the IRG system estimated by Tajima’s π from 7 mouse strains resembles that of classical MHC genes (Figure 3B). That there is also considerable local polymorphism within geographic ranges was confirmed by the identification of numerous heterozygotes at all loci examined by PCR among the wild mouse captures.
-
Figure 3—source data 1
- https://doi.org/10.7554/eLife.01298.008
-
Figure 3—source data 2
- https://doi.org/10.7554/eLife.01298.009
-
Figure 3—source data 3
- https://doi.org/10.7554/eLife.01298.010
-
Figure 3—source data 4
- https://doi.org/10.7554/eLife.01298.011
-
Figure 3—source data 5
- https://doi.org/10.7554/eLife.01298.012
-
Figure 3—source data 6
- https://doi.org/10.7554/eLife.01298.013
With such striking polymorphic diversity in the sequences of proteins known to be involved in resistance against T. gondii, it was appropriate to assay the ability of different IRG genotypes to resist virulent T. gondii. The wild-derived Indian strain CIM, which has a number of divergent IRG alleles (Figure 2B), proved to be remarkably resistant to the type I virulent T. gondii strain, GT-1 (Figure 4A). All CIM mice survived intraperitoneal infection with GT-1 tachyzoites while all laboratory mice (NMRI strain) died within 15 days. In vitro, tachyzoite proliferation of avirulent strains in mouse cells is inhibited by induction of IRG proteins with IFNγ (Könen-Waisman and Howard, 2007). In contrast, proliferation of type I virulent strains is not inhibited (Zhao et al., 2009c). By this assay, IFNγ-induced CIM diaphragm-derived cells (DDC see ‘Materials and methods’) inhibited proliferation of type I virulent RH-YFP strain tachyzoites as efficiently as they inhibited the proliferation of avirulent strains, while BL/6 DDC inhibited only the avirulent strains (Figure 4B). Cells from two other M. m. castaneus strains, CAST/EiJ and CTP were almost as resistant as CIM. Additionally, IFNγ-induced CIM cells died by reactive cell death after infection with both virulent RH-YFP and avirulent ME49, while BL/6 cells died only after infection with avirulent strains (Figure 4C). Reactive death of T. gondii-infected mouse cells after induction with IFNγ is associated with IRG protein-mediated host resistance, as previously reported (Zhao et al., 2009b).
Resistance of CIM mice to the type I virulent RH-YFP strain in vivo was exploited to test linkage of resistance to the IRG system in a (CIM×BL/6)F1×BL/6 backcross. For typing purposes the IRG gene clusters from CIM and BL/6 were differentiated by RFLPs in Irga1 (Chr 18) and Irgb6 (Chr 11). Fluorescent-tagged tachyzoites (RH-YFP) were injected intraperitoneally into mice and the frequency of infected peritoneal cells measured by FACS after 5 days. In five independent experiments involving a total of 65 typed animals (Figure 5A), resistance by this assay was almost completely dominant and was tightly linked to the IRGCIM gene cluster on Chr 11 (p<<10−6). There was no detectable association of virulence with the IRGCIM cluster on Chr 18. In a similar analysis of 53 F2 progeny, mice typed as homozygous IRGCIM at the Chr 11 gene cluster were as resistant as wild-type CIM mice. Thus the reduced resistance of some mice heterozygous for IRGCIM on Chr 11 may be due to a gene dosage effect at the IRG locus. Assayed directly by survival, 51 backcross and F2 mice infected with RH-YFP followed the same pattern as in the peritoneal cell assay (Figure 5B), with the Chr 11 IRGCIM homozygotes (cc in Figure 5B) showing complete resistance, the heterozygotes (bc) substantial but incomplete resistance and the IRGBL/6 homozygotes (bb) complete and acute susceptibility.
Recent results have implicated the inflammasome core component Nlrp1 (NLR family, pyrin domain containing 1) in resistance to T. gondii in human (Witola et al., 2011) and rat (Sergent et al., 2005; Cavailles et al., 2006). Since the Nlrp1 complex locus is about 20 Mb telomeric to the IRG system on Chr 11 it was possible that polymorphism at this locus (Boyden and Dietrich, 2006) was responsible for the differential resistance apparently linked to the IRG complex. We therefore typed all the backcross progeny shown in Figure 5A by PCR designed to distinguish the BL/6 and CIM allotypes of the Nlrp1b locus (see ‘Materials and methods’). We obtained 17% recombinants between Irgb6 and Nlrp1. There was no correlation between Nlrp1 genotype and the ability to clear virulent T. gondii (Figure 5A). It is anyway unlikely that Nlrp1 plays a role in the resistance polymorphism we describe since it is not detectably expressed in the IFNγ-induced DDC transcriptomes (data not shown).
The existence of mouse genotypes resistant to virulent T. gondii strains is consistent with a co-evolutionary explanation for the evolution of virulence. To sustain the argument, however, it would be necessary to show that T. gondii strains that are lethal in laboratory mice, and thereby suffer a major cost, can form functional cysts in resistant CIM mice, permitting their propagation. We therefore searched for brain cysts in CIM mice infected 6–8 weeks earlier with virulent type I or avirulent type III strains of T. gondii. Two type I virulent strains, GT-1 and BK, formed cysts in CIM mice (Figure 5C, Table 1). Thus the resistance of the CIM mouse provides an adaptive niche for highly virulent T. gondii strains. The avirulent type III strain, NED, encysted in the laboratory mice >20× more efficiently than in CIM mice (Table 1).
The IRG resistance mechanism operates cell-autonomously, and in BL/6 cells the loading of IRG proteins onto the parasitophorous vacuole occurs only with avirulent strains even in cells infected simultaneously with virulent and avirulent strains (Zhao et al., 2009a; Khaminets et al., 2010). Consistently, the resistance of the CIM strain against virulent T. gondii was reflected in the behaviour of IRG proteins in IFNγ-induced CIM-derived cells infected with virulent RH-YFP strain T. gondii. In BL/6 cells Irgb6BL/6 loaded onto only about 8% of vacuoles, while in CIM cells the highly divergent Irgb6CIM protein loaded onto more than 50% of vacuoles (Figure 6A). Even more extreme, the tandem protein, Irgb2-b1BL/6, which is poorly expressed in BL/6 cells (Figure 6B), was not detectable on the RH-YFP PVM, while the highly divergent Irgb2-b1CIM was well-expressed in CIM cells and loaded onto over 95% of vacuoles (Figure 6A).
The loading of the effector IRG protein Irga6 onto the parasitophorous vacuole of virulent T. gondii strains is prevented by a parasite-derived kinase complex (ROP5/ROP18) that phosphorylates two threonines that are essential for IRG protein function (Steinfeldt et al., 2010). Remarkably, in CIM cells infected with RH-YFP, phosphorylated Irga6CIM was barely detectable with an antiserum specific for Irga6BL/6 phosphorylated at T108 (Figure 6C). Irga6CIM differs from Irga6BL/6 at only two residues, both distant from the phosphorylation sites and was phosphorylated normally when transfected into IFNγ-induced L929 cells infected with virulent RH-YFP (Figure 6D). Thus Irga6CIM apparently remains unphosphorylated in CIM cells as a result of active inhibition of the parasite kinase complex. The following experiment showed that the highly polymorphic tandem protein, Irgb2-b1CIM, is largely responsible. Irgb2-b1CIM was transfected into IFNγ-induced BL/6 mouse embryonic fibroblasts (MEFs) infected with RH-YFP virulent strain T. gondii. Phosphorylated Irga6 was measured at the PVs in transfected cells expressing Irgb2-b1CIM and in untransfected cells. Figure 6E,F show that the amount of phosphorylated Irga6 was strikingly reduced on vacuoles loaded with Irgb2-b1CIM while the amount of total Irga6 loaded onto Irgb2-b1CIM positive vacuoles was increased (Figure 6G). Thus the decreased signal of phosphorylated Irga6 on the PVM was not caused by competition for loading between Irga6 and Irgb2-b1, but rather by inhibition of phosphorylation. Transfected Irgb2-b1CIM also stimulated the loading of endogenous Irgb6BL/6 onto RH-YFP vacuoles (Figure 6H). Transfected Irgb2-b1BL/6, which is well expressed unlike the endogenous protein, had little or no effect on the loading of Irgb6BL/6 (Figure 6H). Thus the essential difference between Irgb2-b1BL/6 and Irgb2-b1CIM in determining resistance lies in the amino acid sequence polymorphism rather than in the protein expression level.
Preliminary results suggest that Irgb2-b1CIM may bind directly to the protein product of the virulent allele of ROP5. Thus loading of Irgb2-b1CIM onto the PVM of ROP5-deficient RH strain parasites in CIM cells was greatly reduced, and consistently, the amount of loading on to different RH-related strains correlated with strain-specific variation in the amount of ROP5 (Figure 7A). Irgb2-b1CIM itself becomes phosphorylated during infection with virulent T. gondii (Figure 7B), thus is also a target for the active ROP5-ROP18 kinase complex, suggesting that Irgb2-b1CIM may block phosphorylation of Irga6 by binding ROP5 pseudokinase at the vacuole, thereby distracting rather than inhibiting ROP18 kinase. ROP5 binds to Irga6 via helix 4 (H4) of the Irga6 nucleotide binding domain (Fleckenstein et al., 2012), so a homologous structure on Irgb2-b1 may be involved in ROP5 interaction. Indeed the putative H4 and αD structural domains of the Irgb2 subunit are highly polymorphic and show recent divergent selection (Figure 7C), indicating possible co-evolution with ROP kinases and pseudokinases. The high polymorphism of H4 in Irgb2-b1 is also consistent with a direct interaction with a polymorphic component of the pathogen. If Irgb2-b1 interacts with a host protein to bridge to ROP5 the interaction surface between the two host proteins would not be expected to evolve rapidly under divergent selection.
Discussion
We have shown that the IRG protein system essential for resistance against T. gondii infection in the mouse has a complex polymorphism on the scale of the MHC, and that at least one IRG haplotype, found in the wild-derived CIM strain mouse, is strikingly resistant to T. gondii strains that are highly virulent for laboratory mice. We also provide a mechanistic explanation for the resistance of the CIM mouse against type I virulent T. gondii strains. Resistance is determined by the presence of the polymorphic tandem IRG protein, Irgb2-b1CIM encoded on Chr 11, which blocks the ROP5/ROP18 kinase complex of the virulent parasite, preventing phosphorylation and consequent inactivation of IRG effector proteins. Taken together, our results suggest a selective explanation for the evolution of T. gondii strains that are highly virulent for certain mice. If the mouse is an evolutionarily significant host for T. gondii the parasite must balance its virulence against mouse resistance, in order to allow encystment. To minimise the cost of infection, selection on the mouse favours the evolution of strong resistance alleles. This in turn leads to the selection of parasite strains able to counteract heightened resistance sufficiently to allow encystment in these mouse genotypes, as type I T. gondii strains in CIM mice. However such virulent T. gondii strains are counterselected by acute lethality in less resistant mice, while less resistant mice are better hosts for less virulent T. gondii strains.
Why, however, are not all mice highly resistant? Loss of the entire IRG system in several vertebrate groups, for example higher primates and birds (Bekpen et al., 2005), suggests that possession of the IRG system may be costly. Highly resistant genotypes may be more costly than less resistant ones. Alternatively, molecular specificity in interactions between polymorphic parasite virulence factors and mouse IRG proteins may favour IRG genotypes that are highly resistant to some T. gondii genotypes but more susceptible to others. Such an allele-specific system is familiar from polymorphic plant disease resistance (R) genes and strain-specific pathogen virulence and avirulence (Flor 1971; Dodds et al., 2006), where exact molecular matches or mismatches determine the outcome of a given infection. These alternative models can now be analysed formally and tested experimentally.
Much of the argument in this paper has focused on the importance of the house mouse as an intermediate host and vector for T. gondii, resting on the global abundance of the species and its sympatry with the cat, and obviously supported by the intimate antagonistic relationship between T. gondii virulence factors and mouse resistance factors. However, although many bacteria and protozoal parasites are not resisted by the IRG system, T. gondii is not the only organism that is. At least two members of the Chlamydia species complex are resisted by the IRG system in mice, and polymorphic variation on Chr 11, possibly associated with Irgb10, affects the level of resistance (Bernstein-Hanley et al., 2006; Miyairi et al., 2007). There will surely be other organisms that may contribute to the genomic complexity and polymorphism of the IRG system. For example, the massive and ancient polymorphism of Irgb6 is not directly accounted for by our experiments. In in vitro experiments in BL/6 cells transfected Irgb2-b1CIM protects Irga6 from phosphorylation in the absence of the CIM allotypes of the other IRG proteins including Irgb6 (Figure 6) and in the CAST/Ei strain, which is almost as resistant as CIM against T. gondii, Irgb6 is barely expressed (unpublished results). It may be that Irgb6 polymorphism reflects a pattern of resistance against another abundant mouse pathogen. However it is also not excluded that Irgb6 polymorphisms relate to further virulence polymorphism in T. gondii not expressed in the limited range of strains used in the present study. Likewise, mice are not the only intermediate hosts for T. gondii. The parasite infects all known mammals and birds, and many other species than M. musculus are prey for domestic cats. Furthermore, individuals of other species, for example rats (Jacobs and Jones, 1950) and American deer mice (Peromyscus) (Frenkel, 1953) have been shown to resist infection with strains virulent for laboratory mice. Thus some of the genomic complexity of the ROP system and other virulence-associated T. gondii secretory proteins may be relevant to immunity modification in other host species. Nevertheless, despite these distractions, mice and T. gondii have clearly had a large selective impact on each other.
The close association of cat and mouse with humans has led to large-scale transformations in the ecology of the parasite over the last 10,000 years. The impact of the dramatic narrowing of the parasite’s effective host range on the genetics of the virulence-resistance relationship may help to understand better the co-evolutionary forces at work in this system. The patterns of genetic resistance against T. gondii in its most important intermediate hosts will determine the relative abundance of strains contaminating the environment, and thereby the strains available for human infection.
Materials and methods
Nomenclature of IRG genes and proteins
Request a detailed protocolThe systematic, phylogenetically-based nomenclature of IRG genes and proteins used in this paper was published in Bekpen et al. (2005) and replaced the non-systematic naming of some of the first-discovered members of the family. A partial synonymy relating the new nomenclature to other names that have appeared in the literature is given in Martens and Howard (2006). The root name for members of the IRG family is IRG. This may followed by single letters designating phylogenetically distinct sequence sub-families, as IRGA, IRGB, IRGC, IRGD, IRGM. Individual gene or protein names are given in the standard mouse nomenclatural form, as Irga6 (protein) and Irga6 (gene) or Irgb6 (protein) and Irgb6 (gene). A subset of IRGB genes consist of two adjacent IRG coding units that are transcribed together from single promoters and spliced to form ‘tandem’ IRG proteins with a molecular weight twice that of the individual IRG coding units. In the original study it was not clear whether the individual coding units could also be expressed separately and they were therefore given separate names (as Irgb1 and Irgb2) (Bekpen et al., 2005). It is now clear that these coding units are expressed only as tandems. In the present study we have therefore named the tandem genes and proteins with the names of their constituent coding units in N-C order, thus Irgb2-b1 is a tandem IRG protein with the Irgb2 coding unit N-terminal to the Irgb1 coding unit.
Sequencing and assembly of IRG genes of inbred mouse strains and wild mice
Request a detailed protocolThe Mus musculus genomes sequenced by the Mouse Genomes Project (MGP) (Keane et al., 2011), including 129P2/OlaHsd, 129S1/SvImJ, 129S5/SvEvBrd, A/J, AKR/J, BALB/cJ, C3H/HeJ, C57BL/6NJ, CAST/EiJ, CBA/J, DBA/2J, FVB/N, LP/J, NOD/ShiLtJ, NZO/HlLtJ, PWK/PhJ, WSB/EiJ and the Mus spretus genome, SPRET/EiJ, were accessed by LookSeq (http://www.sanger.ac.uk/resources/mouse/genomes/), and the sequences of IRG genes were assembled (for details see below, ‘Bioinformatics’). Three 129 strains (129P2/OlaHsd, 129S1/SvImJ and 129S5/SvEvBrd) were identical in all IRG coding units, so they were combined into one virtual strain, 129. Mouse strain C57BL/6NJ was confirmed identical for all IRG genes with C57BL/6J, so the results were combined into one strain, C57BL/6. The sequences of IRG genes of mouse strains Czech II, NMRI and JYG were acquired from the NCBI database and are listed in Table 2. The CAST/Ei BAC library CHORI-26 was screened with 40bp synthetic probes for Irga1, Irga3, Irga4, Irga6, Irgm1, Irgm2, Irgb1, Irgb6, Irgb8 and Irgb10. Eight out of 61 positive BAC clones were sent to the Wellcome Trust Sanger Institute for shotgun sequencing as follows: 226N16 (NCBI accession number CU695224), 243M20 (CU695226), 445J9 (CU695230), 332A4 (CU695228), 333C17 (CU695229), 240F21 (CU695225), 316B17 (CU695227) and 76B7 (CU695231). The sequences of IRG genes were extracted from these results and cross-checked with the data from the MGP. Clones containing IRG genes from the mouse strain MSM/Ms (Abe et al., 2004) were chosen based on the BAC end sequences from RIKEN BRC (http://www.brc.riken.jp/lab/dna/en/MSMBACen.html). Seven clones were sent to the Beijing Genomics Institute (BGI) for Illumina sequencing: 329H21, 362F04, 544P17, 494M12, 419B05, 148E20 and 355D01. The sequencing results were assembled and uploaded to the NCBI GenBank with accession number KF705682, KF705684, KF705686, KF705680, KF705685, KF705681, KF705683. IRG genes of the CIM mouse strain were sequenced via full transcriptome Illumina sequencing of IFNγ-induced diaphragm-derived cells (DDC, see below) in the Cologne Centre of Genomics (CCG). For wild mouse samples, genomic DNA was acquired from a variety of sources. From this material 5 key IRG members were amplified by PCR with appropriate primers (Table 3). The full ORFs of Irgm1, Irgb2, Irgb6 and Irgb10, and a partial sequence of Irga6 (964 bp in length) were amplified. PCR products were cloned into the pGEM-T vector and insertions in individual positive clones were sequenced. The sequences are attached as supplementary files in FASTA format.
Bioinformatics and sequence analysis
Request a detailed protocolNeighbor-joining trees of IRG genes and proteins were built with MEGA5 (Tamura et al., 2011). The MSM/Ms BAC Illumina data were assembled de novo with the assistance of Geneious Pro 5.5.6 (Biomatters Ltd.). Dot plots of genomic IRG gene clusters of BL/6 vs CIM and BL/6 vs MSM/Ms were calculated by LBDOT 1.0 (Lynnon Corporation) with a sliding window of 20 bp and a maximum mismatch of 2 bp. The raw Illumina reads from inbred mouse strains were accessed by LookSeq and all reads were grouped based on SNPs and manually aligned to their BL/6 homologues. Individual IRG gene sequences are available through Genbank. For analysis of the average diversity between house mouse strains, the sequences of 50 random functional genes were acquired from MGP and the National Institute of Genetics (NIG), Japan (http://molossinus.lab.nig.ac.jp/msmdb/). The analysis covered seven mouse strains: two laboratory inbred strains, BL/6 (MHC haplotype b) and AKR/J (MHC haplotype k); four wild-derived inbred house mouse strains, MSM/Ms, CAST/EiJ, PWK/PhJ and WSB/EiJ; the M. spretus strain Spretus/EiJ. As shown in Figure 3—source data 1, genes were arbitrarily selected based on numerical position in the NCBI reference assembly build 37. Potentially functional genes closest to the designated genome position with EST evidence on the NCBI database were chosen. If the ORF of the gene was longer than 1500 bp, only 1500 bp were considered. Tajima’s π and πa/πs values were calculated with DnaSP5 (Librado and Rozas, 2009). The secondary structure of Irgb2-b1 was predicted by PSIpred (UCL department of computer science, http://bioinf.cs.ucl.ac.uk/psipred/).
Culture of T. gondii strains
Request a detailed protocolT. gondii strains (Table 4) were maintained by serial passage in confluent monolayers of Hs27 cells. When Hs27 cells were lysed by T. gondii tachyzoites, parasites were harvested from the supernatant and purified from host cell debris by differential centrifugation (5 min at 100×g, 15 min at 500×g). The pelleted parasites were resuspended in IMDM, 5% FCS supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin (PAA, Pasching, Austria), counted and immediately used for infection of mice, cells or lysed for subsequent immunoblot.
Rationale for assay of specific IRG proteins in these experiments
Request a detailed protocolThe IRG proteins all have distinctive properties. Irga6 and Irgb6 are the most highly expressed (in lab mice) and there are excellent serological reagents available for them. We therefore used Irga6 and Irgb6 for experiments that monitor loading at the vacuole. In addition, we have antisera against the specific phosphoserines on Irga6 so we can measure phosphorylation directly. Irgb6 is however more drastically affected by the genetic difference between avirulent types II and III T. gondii strains and virulent type I strains, dropping from up to 90% loading of vacuoles to around 10%. Irga6 is also greatly affected but the effect is seen more conspicuously as a reduction in the intensity of loading rather than in a reduction in the percent of vacuoles detectably loaded. These and other distinctive properties, are described elsewhere (Khaminets et al., 2010; Steinfeldt et al., 2010; Fleckenstein et al., 2012). The tandem IRG protein, Irgb2-b1, became a focus of attention because of its high expression in resistant CIM mice, its large polymorphic variation, and evidence for being under recent divergent selection (see below).
Preparation of tissue culture lines from mouse diaphragm cells
Request a detailed protocolThe origins of mice used in this study are listed in Table 5. Cells were prepared from diaphragm tissue by a modification of the technique described by Antony et al., (1989). Diaphragm-derived cells are easy to prepare and have the advantage over MEFs that they can be prepared from a single adult mouse, enabling individual genetically different animals to be studied genetically and functionally at the cellular level. One mouse from each of BL/6, CAST/EiJ, CTP and CIM strains was sacrificed and the diaphragm removed under sterile conditions. The diaphragm was washed with PBS, chopped up, incubated with collagenase/dispase (1 mg/ml, Roche, Mannheim, Germany) for 1 hr at 37°C and then centrifuged for 15 s at 100×g. The supernatant was collected, centrifuged for 5 min at 500×g and the pellet plated in DMEM, 10% FCS supplemented with 4 mM L-glutamine, 2 mM non-essential amino acids, 1 mM sodium pyruvate, 1× MEM non-essential amino acids, 100 U/ml penicillin, 100 μg/ml streptomycin (all PAA, Pasching, Austria). The remaining cell debris after collagenase/dispase-incubation was further incubated in 1× trypsin (Gibco, Grand Island, New York, USA) for 1 hr at 37°C, and then centrifuged for 15 s at 100×g. The supernatant was collected, centrifuged for 5 min at 500×g and the pellet plated (see above). Primary diaphragm-derived cells (DDC) were grown until they had reached ∼50% confluence and then transfected with 2 µg of psv3-neo (Southern and Berg, 1982) using the FuGENE HD transfection reagent (Roche, Mannheim, Germany) according to the manufacturer’s protocol. Cells were put under selection with G418 (Geneticin, PAA, Pasching, Austria) at a concentration of 150 μg/ml until immortalised clones had overgrown the culture. DDC isolated from mice and the mouse cell line L929 (from mouse strain C3H) were maintained in supplemented DMEM (see above) without G418.
Cell induction, transfection and infection
Request a detailed protocolCells were induced for 24 hr with 200 U/ml of IFNγ (Peprotech, Rocky Hill, New York, USA) unless indicated otherwise. Irga6BL/6 and Irga6CIM were cloned into the pGW1H vector with C-terminal ctag1 tags (Martens et al., 2005); full length Irgb2-b1BL/6 and Irgb2-b1CIM were cloned into the pGW1H vector with C-terminal Flag tags. Constructs were transfected using FuGENE HD Transfection Reagent (Roche, Mannheim, Germany) according to the manufacturer’s protocol. The multiplicities of infection (MOI) were 1 for the 3H-uracil incorporation assay, 2–5 for immunofluorescence microscopy, 2.5, 5 and 10 for the cell viability assay, and ∼10 for in-cell phosphorylation experiments. Cells were either fixed for immunofluorescence or lysed for western blot 2 hr after infection.
Immunofluorescence microscopy and analysis
Request a detailed protocolCells were fixed with PBS/3% paraformaldehyde (PFA) for 20 min at room temperature (RT), washed three times with PBS and then permeabilized with 100% methanol on ice (for stainings including serum 87,558, below) or PBS/0.1% saponin at RT (all other antibodies) for 10 min followed by blocking with PBS/3% bovine serum albumin (BSA) for 1 hr. Cells were incubated with primary antibodies diluted in PBS/3% BSA for 1 hr and subsequently incubated with secondary antibodies for 30 min at RT. Antibodies against Irgb6 (141/1) and against the conserved Irgb-tandem C-terminal peptide CLSDLPEYWETGMEL (954/1-C15A) shared by Irgb-tandem proteins of both BL/6 and CIM mice raised at Innovagen AB (Lund, Sweden). Rabbit polyclonal anti-Irga6 phosphorylated at T108 has been described (serum 87,558) (Steinfeldt et al., 2010). Other primary immunoreagents were anti-recombinant Irga6 antiserum 165/3 (Martens et al., 2004), mouse anti-FLAG (M2, Sigma-Aldrich, St. Louis, Missouri, USA) and rabbit anti-calnexin (Calbiochem, Darmstadt, Germany). Second-stage antibodies were: Alexa 488 and Alexa 555 labelled donkey anti-mouse and anti-rabbit sera (Molecular Probes, Eugene, Oregon, USA). Images were taken with a Zeiss Axioplan II fluorescence microscope equipped with an AxioCam MRm camera (Zeiss, Jena, Germany). Images were processed with Axiovision 4.7 (Zeiss, Jena, Germany). Quantification of IRG protein signal intensity at the T. gondii PVM was performed as described before (Khaminets et al., 2010). All quantification of microscopical images was performed double blind. Error bars in Figure 6A,G represent standard deviations of repeated measurements.
Western blot analysis
Request a detailed protocol4×105 cells were seeded to individual wells of a six-well plate and induced with IFNγ for 24 hr. Cell lysis and western blot analysis was performed essentially as described elsewhere (Steinfeldt et al., 2010).
Immunoprecipitation
Request a detailed protocol6×105 BL/6 and CIM DDC were seeded in 6-cm dishes and induced with IFNγ for 24 hr. Metabolic labelling with 33P-phosphoric acid (Hartmann Analytic, Braunschweig, Germany), cell lysis and immunoprecipitation was performed essentially as described elsewhere (Steinfeldt et al., 2010).
In vitro 3H-uracil incorporation assay for measuring T. gondii proliferation
Request a detailed protocolT. gondii proliferation was measured using the 3H-uracil incorporation assay (Pfefferkorn and Guyre, 1984). DDC were seeded on 96-well plates (6500 cells/well) and induced with IFNγ (100 U/ml) or left untreated. 24 hr after induction cells were infected for a further 24 hr with specified T. gondii strains at different multiplicities of infection, or left uninfected. The cultures were labeled with 0.3 μCi/well of 3H-uracil (3HU, Hartmann Analytic, Braunschweig, Germany) for 24 hr and then frozen at −20°C. The amount of radioactivity incorporated into proliferating parasites was determined by a MatrixTM 9600 β-counter (Packard, Meriden, Connecticut, USA). Data are shown for MOI = 1 and presented as the percentage of residual parasite proliferation under IFNγ treatment (Figure 4B). Residual parasite proliferation was defined as follows: 100—([3HU counts—background in infected, IFNγ-treated culture/mean 3HU counts—background in infected, non-treated cultures] ×100) where background is 3HU (mean) counts of uninfected, non-induced cultures.
Cell viability assay
Request a detailed protocolDDC were seeded and induced as described for the 3H-uracil incorporation assay (see above). Cells were infected with type I RH-YFP or type II ME49 strains of T. gondii with indicated MOIs for 8 hr. Viable cells were quantified by the CellTiter 96 AQueous non-radioactive cell proliferation assay (Promega, Madison, Wisconsin, USA) according to the manufacturer’s protocol. The absorption of a bioreduced formazan of the tetrazolium compound MTS, which is generated by metabolically active cells during incubation at 37°C for 2–4 hr, was measured in an ELISA reader (Molecular Devices, Menlo Park, California, USA) at 490 nm. The quantity of formazan product is proportional to the number of living cells in the culture.
In vivo survival assay and genotyping
Request a detailed protocolMice were infected i.p. with 500 RH-YFP tachyzoites in 200 µl of PBS and tail samples were taken when animals succumbed during the acute phase of infection. Survivors were sacrificed 60 days post infection, tested for sero-conversion using the Toxocell Latex Kit (biokit, Barcelona, Spain) and tail biopsies taken. Biopsies were digested in 500 µl of buffer (100 mM Tris-HCl [pH 8.5], 5 mM EDTA, 200 mM NaCl, 0.2% SDS, 150 µg/ml proteinase K) and genomic DNA precipitated with isopropanol. An 804 bp fragment of Irga1 and an 857 bp fragment of Irgb6 were amplified from genomic DNA using the primers listed in Table 3. PCR products were digested with restriction enzymes AccI (Irga1) or FokI (Irga6, both New England BioLabs, Ipswich, Massachusetts, USA) for 45 min at 37°C, followed by 20 min at 60°C. DNA fragments were separated on a 2% agarose gel. Nlrp1b fragments were amplified with a universal forward primer and strain-specific backward primers (BL/6 or CIM, see Table 3).
Flow cytometry to assay infected peritoneal cells
Request a detailed protocolMice were infected i.p. with 500 RH-YFP tachyzoites, sacrificed on day 5 post infection and subsequently subjected to peritoneal lavage with 6 ml of PBS. Lavage suspension (1 ml) was centrifuged in microtubes for 5 min at 500×g, the supernatant was discarded, the cell pellet resuspended with 30 µl of PBS/0.5% BSA containing PE-conjugated rat anti-mouse CD45 antibody (BD Biosciences, San Jose, California, USA) and subsequently incubated for 20 min on 4°C in the dark. The microtubes were then filled with PBS/0.5% BSA, centrifuged for 5 min at 500×g, the supernatant discarded and stained cells resuspended in 300 µl of PBS/0.5% BSA. Cells were analysed using a BD FACS Calibur flow cytometer (BD Biosciences, San Jose, California, USA) and the percentage of infected CD45-positive cells was calculated as percentage of events positive for YFP over 5×104 CD45-positive cells using WinMDI 2.9.
Quantitation of T. gondii in brains of infected mice
Request a detailed protocolMice were infected with T. gondii tachyzoites in 200 µl of PBS as indicated in Table 1. 6–8 weeks (GT-1 and BK) or 5 weeks (NED) post infection mice were sacrificed, the brains removed and triturated in 1 ml of PBS. Cysts were counted in 15–20 drops of 10 µl per brain homogenate to estimate the total number of cysts per brain. Additionally, homogenised mouse brains were digested with proteinase K (final concentration 100 μg/ml) overnight, and total genomic DNA was isolated with DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. The presence of T. gondii DNA was detected with a Taqman qPCR method (7900fast; Applied Biosystems, Foster City, California, USA) by primer Tox-9 and Tox-11 as described before (Reischl et al., 2003).
Statistical analysis
Request a detailed protocolDifferences were tested for statistical significance using the unpaired two-tailed Student’s t test.
Data availability
-
Mus musculus molossinus clone MSMg01-329H21ID KF705682. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mus musculus molossinus clone MSMg01-362F04ID KF705684. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mus musculus molossinus clone MSMg01-544P17ID KF705686. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mus musculus molossinus clone MSMg01-494M12ID KF705680. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mus musculus molossinus clone MSMg01-419B05ID KF705685. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mus musculus molossinus strain MSM/Ms clone MSMg01-148E20ID KF705681. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mus musculus molossinus clone MSMg01-355D01ID KF705683. Publicly available at GenBank (http://www.ncbi.nlm.nih.gov/genbank/).
-
Mouse Genomes ProjectThese data are released in accordance with the Fort Lauderdale agreement and Toronto agreements.
-
NIG Mouse Genome DatabaseAvailable at NIG Mammalian Genetics Laboratory, Japan.
-
Mus musculus castaneus strain CAST/Ei clone CH26-332A4ID CU695228. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mus musculus castaneus strain CAST/Ei clone CH26-226N16ID CU695224. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mouse DNA sequence from clone CH26-243M20 on chromosome 11, complete sequenceID CU695226. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mouse DNA sequence from clone CH26-455J9 on chromosome 11, complete sequenceID CU695230. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mouse DNA sequence from clone CH26-333C17 on chromosome 11, complete sequenceID CU695229. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mus musculus castaneus strain CAST/Ei clone CH26-240F21ID CU695225. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mouse DNA sequence from clone CH26-316B17 on chromosome 18, complete sequenceID CU695227. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
-
Mouse DNA sequence from clone CH26-76B7 on chromosome 18, complete sequenceID CU695231. Publicly available at the NCBI Nucleotide database (http://www.ncbi.nlm.nih.gov/nuccore).
References
-
Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinasesProc Natl Acad Sci USA 108:9631–9636.https://doi.org/10.1073/pnas.1015338108
-
Kiss and spit: the dual roles of Toxoplasma rhoptriesNat Rev Microbiol 6:79–88.https://doi.org/10.1038/Nrmicro1800
-
Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activationLab Invest 75:827–841.
-
Mouse pathogenicity of Toxoplasma gondii isolated from a goatAm J Vet Res 41:427–429.
-
Advances in the life cycle of Toxoplasma gondiiInt J Parasitol 28:1019–1024.https://doi.org/10.1016/S0020-7519(98)00023-X
-
Current status of the gene-for-gene conceptAnnu Rev Phytopathol 9:275–296.https://doi.org/10.1146/annurev.py.09.090171.001423
-
Host, strain and treatment variation as factors in the pathogenesis of toxoplasmosisAm J Trop Med Hyg 2:390–414.
-
High-throughput growth assay for Toxoplasma gondii using yellow fluorescent proteinAntimicrob Agents Chemother 47:309–316.https://doi.org/10.1128/AAC.47.1.309-316.2003
-
The parasitemia in experimental toxoplasmosisJ Infect Dis 87:78–89.https://doi.org/10.1093/infdis/87.1.78
-
Cell-autonomous immunity to Toxoplasma gondii in mouse and manMicrobes Infect 9:1652–1661.https://doi.org/10.1016/j.micinf.2007.09.005
-
The interferon-inducible GTPasesAnnu Rev Cell Dev Biol 22:559–589.https://doi.org/10.1146/annurev.cellbio.22.010305.104619
-
Mechanisms regulating the positioning of mouse p47 resistance GTPases LRG-47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced by phagocytosisJ Immunol 173:2594–2606.
-
The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infectionJ Immunol 179:1814–1824.
-
Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferonInfect Immun 44:211–216.
-
Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulenceProc Natl Acad Sci USA 108:9625–9630.https://doi.org/10.1073/pnas.1015980108
-
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoterJ Mol Appl Genet 1:327–341.
-
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTPProc Natl Acad Sci USA 97:751–755.https://doi.org/10.1073/pnas.97.2.751
-
Isolation of Toxoplasma from cerebrospinal fluid of a living infant in HollandProc Soc Exp Biol Med 67:292–294.https://doi.org/10.3181/00379727-67-16279
Article and author information
Author details
Funding
Deutsche Forschungsgemeinschaft (SFB 680, SFB 635, SFB 670 and SPP 1399)
- Jingtao Lilue
- Urs Benedikt Müller
- Tobias Steinfeldt
- Jonathan C Howard
International Graduate School in Development Health and Disease
- Urs Benedikt Müller
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Acknowledgements
We thank Claudia Poschner for outstanding technical support. Stephanie Könen-Waisman helped with double-blind evaluation of IRG protein loading onto T. gondii vacuoles. We thank Miriam Linnenbrink and Christine Pfeifle (MPI Evolutionary Biology, Plön) for expertise in handling wild mice, and Christine Pfeifle for maintaining the CIM strain in Plön. Annie Orth and François Bonhomme (U Montpellier) provided the CIM breeding colony. Uma Ramakrishnan and colleagues at the NCBI, Bangalore provided the facilities to prepare cells from locally caught wild mice. Olaf Utermoehlen (U Cologne) provided facilities for the infection of wild mice with T. gondii. Carsten Lüder (U Göttingen) and Ildiko Dunay (U Magdeburg) advised on identification and analysis of T. gondii cysts in vivo. Aurélien Tellier (LMU, Munich) and Stephan Schiffels (U Cologne) contributed to analysis of the sequence alignments. We are grateful to Paul Schulze-Lefert (Cologne), Paul Schmid-Hempel (Zurich) and Isabel Gordo (Oeiras) for comments on the manuscript.
Ethics
Animal experimentation: All animal experiments were conducted under the regulations and protocols for animal experimentation by the local government authorities (Bezirksregierung Köln, Germany), LANOV Nordrhein-Westfalen Permit No. 44.07.189.
Copyright
© 2013, Lilue et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,496
- views
-
- 376
- downloads
-
- 90
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
- Microbiology and Infectious Disease
Variant calling is fundamental in bacterial genomics, underpinning the identification of disease transmission clusters, the construction of phylogenetic trees, and antimicrobial resistance detection. This study presents a comprehensive benchmarking of variant calling accuracy in bacterial genomes using Oxford Nanopore Technologies (ONT) sequencing data. We evaluated three ONT basecalling models and both simplex (single-strand) and duplex (dual-strand) read types across 14 diverse bacterial species. Our findings reveal that deep learning-based variant callers, particularly Clair3 and DeepVariant, significantly outperform traditional methods and even exceed the accuracy of Illumina sequencing, especially when applied to ONT’s super-high accuracy model. ONT’s superior performance is attributed to its ability to overcome Illumina’s errors, which often arise from difficulties in aligning reads in repetitive and variant-dense genomic regions. Moreover, the use of high-performing variant callers with ONT’s super-high accuracy data mitigates ONT’s traditional errors in homopolymers. We also investigated the impact of read depth on variant calling, demonstrating that 10× depth of ONT super-accuracy data can achieve precision and recall comparable to, or better than, full-depth Illumina sequencing. These results underscore the potential of ONT sequencing, combined with advanced variant calling algorithms, to replace traditional short-read sequencing methods in bacterial genomics, particularly in resource-limited settings.
-
- Microbiology and Infectious Disease
The Nix-TB clinical trial evaluated a new 6 month regimen containing three oral drugs; bedaquiline (B), pretomanid (Pa), and linezolid (L) (BPaL regimen) for the treatment of tuberculosis (TB). This regimen achieved remarkable results as almost 90% of the multidrug-resistant or extensively drug-resistant TB participants were cured but many patients also developed severe adverse events (AEs). The AEs were associated with the long-term administration of the protein synthesis inhibitor linezolid. Spectinamide 1599 is also a protein synthesis inhibitor of Mycobacterium tuberculosis with an excellent safety profile, but it lacks oral bioavailability. Here, we propose to replace L in the BPaL regimen with spectinamide (S) administered via inhalation and we demonstrate that inhaled spectinamide 1599, combined with BPa ––BPaS regimen––has similar efficacy to that of the BPaL regimen while simultaneously avoiding the L-associated AEs. The BPaL and BPaS regimens were compared in the BALB/c and C3HeB/FeJ murine chronic TB efficacy models. After 4-weeks of treatment, both regimens promoted equivalent bactericidal effects in both TB murine models. However, treatment with BPaL resulted in significant weight loss and the complete blood count suggested the development of anemia. These effects were not similarly observed in mice treated with BPaS. BPaL and BPa, but not the BPaS treatment, also decreased myeloid to erythroid ratio suggesting the S in the BPaS regimen was able to recover this effect. Moreover, the BPaL also increased concentration of proinflammatory cytokines in bone marrow compared to mice receiving BPaS regimen. These combined data suggest that inhaled spectinamide 1599 combined with BPa is an effective TB regimen without L-associated AEs.